150 related articles for article (PubMed ID: 12535646)
1. A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5).
Lamhonwah AM; Skaug J; Scherer SW; Tein I
Biochem Biophys Res Commun; 2003 Jan; 301(1):98-101. PubMed ID: 12535646
[TBL] [Abstract][Full Text] [Related]
2. Epitope shared by functional variant of organic cation/carnitine transporter, OCTN1, Campylobacter jejuni and Mycobacterium paratuberculosis may underlie susceptibility to Crohn's disease at 5q31.
Lamhonwah AM; Ackerley C; Onizuka R; Tilups A; Lamhonwah D; Chung C; Tao KS; Tellier R; Tein I
Biochem Biophys Res Commun; 2005 Dec; 337(4):1165-75. PubMed ID: 16246312
[TBL] [Abstract][Full Text] [Related]
3. Expression and functional analysis of intestinal organic cation/L-carnitine transporter (OCTN) in Crohn's disease.
Girardin M; Dionne S; Goyette P; Rioux J; Bitton A; Elimrani I; Charlebois P; Qureshi I; Levy E; Seidman EG
J Crohns Colitis; 2012 Mar; 6(2):189-97. PubMed ID: 22325173
[TBL] [Abstract][Full Text] [Related]
4. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
Noble CL; Nimmo ER; Drummond H; Ho GT; Tenesa A; Smith L; Anderson N; Arnott ID; Satsangi J
Gastroenterology; 2005 Dec; 129(6):1854-64. PubMed ID: 16344054
[TBL] [Abstract][Full Text] [Related]
5. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease.
Babusukumar U; Wang T; McGuire E; Broeckel U; Kugathasan S
Am J Gastroenterol; 2006 Jun; 101(6):1354-61. PubMed ID: 16771961
[TBL] [Abstract][Full Text] [Related]
6. Carnitine transport: pathophysiology and metabolism of known molecular defects.
Tein I
J Inherit Metab Dis; 2003; 26(2-3):147-69. PubMed ID: 12889657
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
Tamai I
Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
[TBL] [Abstract][Full Text] [Related]
8. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
[TBL] [Abstract][Full Text] [Related]
9. Expression of OCTN2 and OCTN3 in the apical membrane of rat renal cortex and medulla.
Cano MM; Calonge ML; Ilundain AA
J Cell Physiol; 2010 May; 223(2):451-9. PubMed ID: 20112288
[TBL] [Abstract][Full Text] [Related]
10. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.
Inano A; Sai Y; Kato Y; Tamai I; Ishiguro M; Tsuji A
Drug Metab Pharmacokinet; 2004 Jun; 19(3):180-9. PubMed ID: 15499185
[TBL] [Abstract][Full Text] [Related]
11. Organic cation/carnitine transporter OCTN3 is present in astrocytes and is up-regulated by peroxisome proliferators-activator receptor agonist.
Januszewicz E; Pajak B; Gajkowska B; Samluk L; Djavadian RL; Hinton BT; Nałecz KA
Int J Biochem Cell Biol; 2009 Dec; 41(12):2599-609. PubMed ID: 19735737
[TBL] [Abstract][Full Text] [Related]
12. Molecular and functional characterization of organic cation/carnitine transporter family in mice.
Tamai I; Ohashi R; Nezu JI; Sai Y; Kobayashi D; Oku A; Shimane M; Tsuji A
J Biol Chem; 2000 Dec; 275(51):40064-72. PubMed ID: 11010964
[TBL] [Abstract][Full Text] [Related]
13. Functional variants of OCTN cation transporter genes are associated with Crohn disease.
Peltekova VD; Wintle RF; Rubin LA; Amos CI; Huang Q; Gu X; Newman B; Van Oene M; Cescon D; Greenberg G; Griffiths AM; St George-Hyslop PH; Siminovitch KA
Nat Genet; 2004 May; 36(5):471-5. PubMed ID: 15107849
[TBL] [Abstract][Full Text] [Related]
14. OCTNs: will the real IBD5 gene please stand up?
Silverberg MS
World J Gastroenterol; 2006 Jun; 12(23):3678-81. PubMed ID: 16773684
[TBL] [Abstract][Full Text] [Related]
15. Regulation of testis-specific carnitine transporter (octn3) gene by proximal cis-acting elements Sp1 in mice.
Maeda T; Hirayama M; Kobayashi D; Tamai I
Biochem Pharmacol; 2005 Sep; 70(6):858-68. PubMed ID: 16051193
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the IBD5 locus to Crohn's disease in the Swedish population.
Törkvist L; Noble CL; Lördal M; Sjöqvist U; Lindforss U; Nimmo ER; Löfberg R; Russell RK; Satsangi J
Scand J Gastroenterol; 2007 Feb; 42(2):200-6. PubMed ID: 17340776
[TBL] [Abstract][Full Text] [Related]
17. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria.
Lamhonwah AM; Tein I
Biochem Biophys Res Commun; 2006 Jul; 345(4):1315-25. PubMed ID: 16729965
[TBL] [Abstract][Full Text] [Related]
18. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease.
Silverberg MS; Duerr RH; Brant SR; Bromfield G; Datta LW; Jani N; Kane SV; Rotter JI; Philip Schumm L; Hillary Steinhart A; Taylor KD; Yang H; Cho JH; Rioux JD; Daly MJ;
Eur J Hum Genet; 2007 Mar; 15(3):328-35. PubMed ID: 17213842
[TBL] [Abstract][Full Text] [Related]
19. PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis.
Koch A; König B; Stangl GI; Eder K
Exp Biol Med (Maywood); 2008 Mar; 233(3):356-65. PubMed ID: 18296741
[TBL] [Abstract][Full Text] [Related]
20. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
